Ad hoc releases are announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
View Featured news and Pulse updates.
Header
Showing 390 results
January 2018
-
Story Discovery
Tracking patients’ progress with radio signals and machine learning
Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.
-
Story Discovery
Organic dealmaker for drug discovery
New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
-
Story Discovery
Open science demystified
Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.
December 2017
-
Story Access to Healthcare
Pioneering business approach expands healthcare in Indian villages
Healthy Family program combines health education with improved access to doctors and medicines.
-
Story Patient Perspectives
One boy’s quest to battle cancer
After a diagnosis of childhood cancer, Ryan faced the diagnosis and treatment of leukemia head- on with the support of his family and community.
-
Story Discovery
Researchers overcome hurdles to test experimental malaria drug
The race is on to find a new treatment before resistance to today’s drugs becomes widespread.
November 2017
-
Story Discovery
Small viruses could accelerate cell and gene therapy research
Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.
-
Story Patient Perspectives
Conversations with Patient Advocates: Ron Hollander, president of INCA
Ron Hollander, president of the International Neuroendocrine Cancer Alliance, talks to us about patient advocacy.
-
Story Patient Perspectives
Targeting the roots of Sjögren’s syndrome
Early clinical trial reports results in this hidden disease
-
Story Discovery
Exploring longstanding questions about heart disease
New Global Head of Cardiovascular and Metabolic Diseases Research looks to apply new tools to address tough challenges.
